news details |
|
|
| VECTOR BORNE DISEASES | | |
Anusha Gul Batt
Vectors are living organisms that can transmit infectious pathogens between humans, or from animals to humans. Many of these vectors are bloodsucking insects, which ingest disease-producing microorganisms during a blood meal from an infected host (human or animal) and later transmit it into a new host, after the pathogen has replicated. Often, once a vector becomes infectious, they are capable of transmitting the pathogen for the rest of their life during each subsequent bite/blood meal.
Vector borne diseases are human illnesses caused by parasites, viruses and bacteria that are transmitted by vectors. Every year there are more than 700,000 deaths from diseases such as malaria, dengue, Schistosomiasis, Human African trypanosomes, Leishmaniasis, Chagas disease, Yellow fever, Japanese encephalitis and Onchocerciasis.
The burden of these diseases is highest in tropical and subtropical areas, and they disproportionately affect the poorest populations. Since 2019, major outbreaks of dengue, malaria, chikungunya, yellow fever and Zika have afflicted populations, claimed lives, and overwhelmed health systems in many countries. Other diseases such as Chikungunya, leishmaniasis and lymphatic filariasis cause chronic suffering, life-long morbidity, disability and occasional stigmatisation.
Distribution of vector-borne diseases is determined by a complex set of demographic, environmental and social factors, global travel and trade and unplanned urbanization.
WHO RESPONSE
The “Global Vector Control Response (GVCR) 2019–2030” was approved by the World Health Assembly in 2017. It provides strategic guidance to countries and development partners for urgent strengthening of vector control as a fundamental approach to preventing disease and responding to outbreaks. To achieve this a re-alignment of vector control programmes is required, supported by increased technical capacity, improved infrastructure, strengthened monitoring and surveillance systems, and greater community mobilization. Ultimately, this will support implementation of a comprehensive approach to vector control that will enable the achievement of disease-specific national and global goals and contribute to achievement of the Sustainable Development Goals and Universal Health Coverage.
WHO Secretariat provides strategic, normative and technical guidance to countries and development partners for strengthening vector control as a fundamental approach based on GVCR to preventing disease and responding to outbreaks. Specifically WHO responds to vector-borne diseases by:
Providing evidence based guidance for controlling vectors and protecting people against infection.
Providing technical support to countries so that they can effectively manage cases and outbreaks.
Supporting countries to improve their reporting systems and capture the true burden of the disease.
Providing training (capacity building) on clinical management, diagnosis and vector control with support from some of its collaborating centres and
Supporting the development and evaluation of new tools, technologies and approaches for vector-borne diseases, including vector control and disease management technologies.
A crucial element in reducing the burden of vector-borne diseases is behavioural change. WHO works with partners to provide education and improve public awareness, so that people know how to protect themselves and their communities from mosquitoes, ticks, bugs, flies and other vectors.
Access to water and sanitation is a very important factor in disease control and elimination. WHO works together with many different government sectors to improve water storage, sanitation, thereby helping to control these diseases at the community level.
KEY FACTS
Vector borne diseases account for more than 17% of all infectious diseases, causing more than 700 000 deaths annually. They can be caused by parasites, bacteria or viruses.
Malaria is a parasitic infection transmitted by Anopheline mosquitoes. It causes an estimated 219 million cases globally, and results in more than 400,000 deaths every year. Most of the deaths occur in children under the age of 5 years.
Dengue is the most prevalent viral infection transmitted by Aedes mosquitoes. More than 3.9 billion people in over 129 countries are at risk of contracting dengue, with an estimated 96 million symptomatic cases and an estimated 40,000 deaths every year.
Other viral diseases transmitted by vectors include chikungunya fever, Zika virus fever, yellow fever, West Nile fever, Japanese encephalitis (all transmitted by mosquitoes), and tick-borne encephalitis (transmitted by ticks).
PREVENTION AND CONTROL
Many of vector borne diseases are preventable, through protective measures, and community mobilisation.
Protect yourselves against stings / bites: Wear loose, light coloured long-sleeved tops and trousers. Use Insecticide Treated Mosquito Nets (ITN) which acts as a barrier. Indoor residual spraying (IRS) of houses, doors, windows and other accessories with insecticides. Use DEET containing insect repellent on exposed parts of the body and clothing.
Prepare for the visit: Wear shoes that cover the entire foot; avoid wearing sandals or open shoes. Tuck trousers into socks or boots to prevent arthropods from reaching the body. Re-apply insect repellents according to instructions.
After the visit: Inspect body parts and clothing. Clear any attached arthropods carefully. Take a soapy shower and wash the clothes. Inspect and clean the bodies of accompanying pets.
TREATMENT
Antimalarial Drug i.e. Amodiaquine plus and Chloroquine is prescribed.
RTS-S vaccine for Plasmodium falciparum.
Tylenol or Paracetamol are prescribed for Dengue.
For Encephalitis Corticosteroids may be administered to reduce Brain’s inflammation.
Miltefosine an oral medication is effective for both visceral and cutaneous leishmaniasis.
For Chagas disease drugs like Azole or Nitro derivatives are recommended.
For Typhus Fever, antibiotics such as Doxycycline and streptomycin is recommended. |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
 |
|
|
